ALKEM.NSNSE
Alkem Laboratories Limited
₹5535.00
ListedDec 23, 2015
SectorHealthcare
IndustryDrug Manufacturers — Specialty & Generic
CountryIndia
Employees-
State-| CityMumbai| AddressAlkem House| Phone91 22 3982 9999
Alkem Laboratories Limited, a pharmaceutical company, engages in the research and development, manufacture, and sale of pharmaceutical and nutraceutical products in India, the United States, and internationally. The company offers branded generics, generic drugs, active pharmaceutical ingredients, and biosimilars, and nutraceuticals in acute and chronic therapeutic areas comprising anti-infective, gastroenterology, pain management, iron deficiency, diabetology, central nervous system, anti-osteoporosis, gynecology, respiratory, ophthalmology, rheumatology, urology, dermatology, cardiology, neurology, and oncology. It also provides vitamins, minerals, and nutrients; cough syrups, hepatoprotective tonic, anti-dandruff shampoo, mouth wash, pregnancy detection kits, and condoms; and anti-bloating syrups, tablets, and powder. The company was incorporated in 1973 and is headquartered in Mumbai, India.

Key Indicators

Key financial and dividend metrics for this stock.

?
P/E Ratio
28.8
?
Div. Rate
₹53.00
?
Div. Yield
0.96%
?
Payout Ratio
26.49%
?
Max Consec. Div. Years
10 years
?
Longest Consec. Div.
10 years
?
Div. Coverage
100%
?
Div. Stability Rate
0.20
?
Div. Growth Rate
75.00%
?
Score
89

Dividend History

Historical dividend payments by ex-dividend date.

Feb 20, 2026
₹ 43.0000
Aug 8, 2025
₹ 8.0000
Feb 14, 2025
₹ 37.0000
Aug 9, 2024
₹ 5.0000
Feb 16, 2024
₹ 35.0000
Aug 10, 2023
₹ 10.0000
Feb 17, 2023
₹ 40.0000
Aug 8, 2022
₹ 4.0000
Feb 10, 2022
₹ 30.0000
Aug 9, 2021
₹ 5.0000
Feb 11, 2021
₹ 25.0000
Aug 10, 2020
₹ 3.0000
Feb 13, 2020
₹ 22.0000
Aug 19, 2019
₹ 8.0000
Feb 15, 2019
₹ 8.0000
Aug 23, 2018
₹ 7.0000
Feb 16, 2018
₹ 6.0000
Aug 31, 2017
₹ 9.0000
Nov 23, 2016
₹ 6.0000
Mar 18, 2016
₹ 9.7000

Peer Companies

Other stocks in the same sector.

The app download will be available in the next version. Stay tuned!